OTR-AC
Shop OTR-AC on KimeraChems · code GUIDE (10% off)Definition
OTR-AC is an investigational compound marketed within the broader SARM research category and is most commonly described as an Ostarine-related analog or variant, although naming conventions vary by supplier. In laboratory settings, OTR-AC is generally positioned as an androgen receptor (AR)-active research compound used to investigate how selective androgen receptor signaling may influence lean-mass retention, strength-related endpoints, and body-composition outcomes under controlled experimental conditions. Because "OTR-AC" is a trade-style designation rather than a universally standardized nonproprietary name, confirmation of compound identity—including analytical verification, purity assessment, and formulation characterization—is considered an important component of experimental design. OTR-AC is not approved for human or veterinary use and is supplied strictly for laboratory and analytical research purposes.
Available Formats
Available formats may vary by supplier.
- Available formats may vary by supplier.
Mechanism of Action
OTR-AC is generally studied as an androgen receptor-active research compound. Common areas of mechanistic investigation include
- Androgen receptor activation: Studied for its ability to bind the androgen receptor and modulate androgen receptor-mediated gene transcription
- Muscle protein regulation: Investigated for effects on signaling pathways involved in skeletal-muscle protein balance and anabolic adaptation
- Tissue selectivity: Explored for differential androgen receptor activity across tissues depending on experimental model, dose, and duration of exposure
- Endocrine regulation: Longer-duration in vivo studies commonly evaluate downstream endocrine-feedback biomarkers during sustained androgen receptor activation
- Formulation-dependent pharmacology: Because experimental outcomes may vary substantially according to compound identity, formulation, purity, and stability, analytical verification is considered essential for meaningful interpretation
Areas of Investigation
OTR-AC is commonly studied in
- Lean-mass retention and accrual under controlled dietary and training conditions
- Strength-related and performance-proxy research
- Comparative androgen receptor pharmacology among SARM-like compounds
- Endocrine feedback and recovery following discontinuation in vivo
- Tissue-specific androgen receptor signaling across skeletal muscle, bone, and other androgen-sensitive tissues
Safety Profile
Reported observations are model- and exposure-dependent and may include
- Suppression-like findings involving endogenous gonadotropin biomarkers in certain in vivo models
- Alterations in lipid-related biomarkers depending on exposure level and study duration
- Changes in hepatic-enzyme measurements in selected exposure paradigms
- Androgenic findings in non-target tissues when tissue selectivity is exceeded or exposure is prolonged
- Rebound changes in endocrine biomarkers following discontinuation in some experimental models
Interaction Notes
OTR-AC is often explored alongside interventions that overlap with androgenic and anabolic signaling.
For educational purposes only. Not for human consumption.